Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr Oncol
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis | The BMJ
Endpoints in adjuvant trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Marc E. Buyse. - ppt download
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
Progression Free Survival - an overview | ScienceDirect Topics
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
JCM | Free Full-Text | Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Survival in oncology reimbursement decision-making | CMAR
Cancer Research and Treatment
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
Frontiers | What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
Time to second subsequent therapy as an endpoint. Progression-free... | Download Scientific Diagram
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper